{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:49:36Z","timestamp":1781336976644,"version":"3.54.1"},"posted":{"date-parts":[[2023,10,22]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":44,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  In the thirteen years since the first report of\n                  <jats:italic>pfhrp2<\/jats:italic>\n                  -deleted parasites in 2010, the World Health Organization (WHO) has found that 40 of 47 countries surveyed worldwide have reported\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  gene deletions. Due to a high prevalence of\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions causing false-negative HRP2 RDTs, in the last five years, Eritrea, Djibouti and Ethiopia have switched or started switching to using alternative RDTs, that target pan-specific-pLDH or\n                  <jats:italic>P. falciparum<\/jats:italic>\n                  specific-pLDH alone of in combination with HRP2. However, manufacturing of alternative RDTs has not been brought to scale and there are no WHO prequalified combination tests that use Pf-pLDH instead of HRP2 for\n                  <jats:italic>P. falciparum<\/jats:italic>\n                  detection. For these reasons, the continued spread of\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions represents a growing public health crisis that threatens efforts to control and eliminate\n                  <jats:italic>P. falciparum<\/jats:italic>\n                  malaria. National malaria control programmes, their implementing partners and test developers desperately seek\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletion data that can inform their immediate and future resource allocation. In response, we use a mathematical modelling approach to evaluate the global risk posed by\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions and explore scenarios for how deletions will continue to spread in Africa. We incorporate current best estimates of the prevalence of\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions and conduct a literature review to estimate model parameters known to impact the selection of\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions for each malaria endemic country. We identify 20 countries worldwide to prioritise for surveillance and future deployment of alternative RDT, based on quickly selecting for\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions once established. In scenarios designed to explore the continued spread of deletions in Africa, we identify 10 high threat countries that are most at risk of deletions both spreading to and subsequently being rapidly selected for. If HRP2-based RDTs continue to be relied on for malaria case management, we predict that the major route for\n                  <jats:italic>pfhrp2<\/jats:italic>\n                  deletions to spread is south out from the current hotspot in the Horn of Africa, moving through East Africa over the next 20 years. We explore the variation in modelled timelines through an extensive parameter sensitivity analysis and despite wide uncertainties, we identify three countries that have not yet switched RDTs (Senegal, Zambia and Kenya) that are robustly identified as high risk for\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions. These results provide a refined and updated prediction model for the emergence of\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  deletions in an effort to help guide\n                  <jats:italic>pfhrp2\/3<\/jats:italic>\n                  policy and prioritise future surveillance efforts and innovation.\n                <\/jats:p>","DOI":"10.1101\/2023.10.21.23297352","type":"posted-content","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T20:20:12Z","timestamp":1698006012000},"source":"Crossref","is-referenced-by-count":19,"title":["Global risk of selection and spread of\n                  <i>Plasmodium falciparum<\/i>\n                  histidine-rich protein 2 and 3 gene deletions"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-0741","authenticated-orcid":false,"given":"Oliver J.","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu Nguyen-Anh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-483X","authenticated-orcid":false,"given":"Robert J","family":"Zupko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasmin","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoor","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rumisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina A","family":"Dzianach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Okell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gething","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej F","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Parr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024010921160386000_2023.10.21.23297352v3.1","unstructured":"World Health Organization, World malaria report 2022 (World Health Organization, 2022; https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022)."},{"key":"2024010921160386000_2023.10.21.23297352v3.2","doi-asserted-by":"crossref","unstructured":"Q. Cheng , M. L. Gatton , J. Barnwell , P. Chiodini , J. McCarthy , D. Bell , J. Cunningham , Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar. J. 13, 283 (2014).","DOI":"10.1186\/1475-2875-13-283"},{"key":"2024010921160386000_2023.10.21.23297352v3.3","unstructured":"World Health Organization, Malaria Threat Map, (available at https:\/\/apps.who.int\/malaria\/maps\/threats\/#\/)."},{"key":"2024010921160386000_2023.10.21.23297352v3.4","doi-asserted-by":"publisher","DOI":"10.3201\/eid2403.171723"},{"key":"2024010921160386000_2023.10.21.23297352v3.5","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41564-021-00962-4","article-title":"Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia","volume":"6","year":"2021","journal-title":"Nat Microbiol"},{"key":"2024010921160386000_2023.10.21.23297352v3.6","unstructured":"World Health Organization, Protocol for estimating the prevalence of pfhrp2\/pfhrp3 gene deletions among symptomatic falciparum patients with false-negative RDT results (2018), (available at http:\/\/www.who.int\/malaria\/publications\/atoz\/hrp2-deletion-protocol\/en\/)."},{"key":"2024010921160386000_2023.10.21.23297352v3.7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2471\/BLT.20.250621","article-title":"Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review","volume":"98","year":"2020","journal-title":"Bull. World Health Organ"},{"key":"2024010921160386000_2023.10.21.23297352v3.8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72083"},{"key":"2024010921160386000_2023.10.21.23297352v3.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1159-z"},{"key":"2024010921160386000_2023.10.21.23297352v3.10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw538"},{"key":"2024010921160386000_2023.10.21.23297352v3.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85913-z"},{"key":"2024010921160386000_2023.10.21.23297352v3.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1752-9"},{"key":"2024010921160386000_2023.10.21.23297352v3.13","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1080\/22221751.2020.1815590","article-title":"Misdiagnosis of imported falciparum malaria from African areas due to an increased prevalence of pfhrp2\/pfhrp3 gene deletion: the Djibouti case","volume":"9","year":"2020","journal-title":"Emerg. Microbes Infect"},{"key":"2024010921160386000_2023.10.21.23297352v3.14","doi-asserted-by":"publisher","DOI":"10.3201\/eid2810.220695"},{"key":"2024010921160386000_2023.10.21.23297352v3.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23881-8"},{"key":"2024010921160386000_2023.10.21.23297352v3.16","doi-asserted-by":"publisher","DOI":"10.1038\/srep02797"},{"key":"2024010921160386000_2023.10.21.23297352v3.17","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.25008"},{"key":"2024010921160386000_2023.10.21.23297352v3.18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12936-021-03739-6","article-title":"HRP2 and HRP3 cross-reactivity and implications for HRP2-based RDT use in regions with Plasmodium falciparum hrp2 gene deletions","volume":"20","year":"2021","journal-title":"Malar. J"},{"key":"2024010921160386000_2023.10.21.23297352v3.19","doi-asserted-by":"crossref","unstructured":"M. L. Gatton , A. Chaudhry , J. Glenn , S. Wilson , Y. Ah , A. Kong , R. L. Ord , R. R. Rees-Channer , P. Chiodini , S. Incardona , Q. Cheng , M. Aidoo , J. Cunningham , Impact of Plasmodium falciparum gene deletions on malaria rapid diagnostic test performance. Malar. J. 19, 392 (2020).","DOI":"10.1186\/s12936-020-03460-w"},{"key":"2024010921160386000_2023.10.21.23297352v3.20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac240"},{"key":"2024010921160386000_2023.10.21.23297352v3.21","unstructured":"World Health Organization, Malaria Threat Maps (2017), (available at http:\/\/apps.who.int\/malaria\/maps\/threats\/)."},{"key":"2024010921160386000_2023.10.21.23297352v3.22","doi-asserted-by":"publisher","DOI":"10.1101\/2022.12.07.519189"},{"key":"2024010921160386000_2023.10.21.23297352v3.23","unstructured":"Malaria Atlas Project Pf Infection Prevalence (per 100 Children). Malaria Atlas Project, (available at https:\/\/data.malariaatlas.org\/trends?year=2020&metricGroup=Malaria&geographicLevel=admin1&metricSubcategory=Pf&metricType=rate&metricName=PR)."},{"key":"2024010921160386000_2023.10.21.23297352v3.24","doi-asserted-by":"crossref","first-page":"e0001235","DOI":"10.1371\/journal.pgph.0001235","article-title":"\u201cTesting for malaria does not cure any pain\u201d A qualitative study exploring low use of malaria rapid diagnostic tests at drug shops in rural Uganda","volume":"2","year":"2022","journal-title":"PLOS Global Public Health"},{"key":"2024010921160386000_2023.10.21.23297352v3.25","unstructured":"Case Management Commodities. Malaria Atlas Projec t, (available at https:\/\/data.malariaatlas.org\/case-management)."},{"key":"2024010921160386000_2023.10.21.23297352v3.26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12936-020-03362-x","article-title":"Molecular surveillance reveals the presence of pfhrp2 and pfhrp3 gene deletions in Plasmodium falciparum parasite populations in Uganda, 2017\u20132019","volume":"19","year":"2020","journal-title":"Malar. J"},{"key":"2024010921160386000_2023.10.21.23297352v3.27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00898-20"},{"key":"2024010921160386000_2023.10.21.23297352v3.28","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3201\/eid2706.204557","article-title":"Role of Anopheles stephensi Mosquitoes in Malaria Outbreak, Djibouti, 2019","volume":"27","year":"2021","journal-title":"Emerging Infectious Disease journal"},{"key":"2024010921160386000_2023.10.21.23297352v3.29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1229045"},{"key":"2024010921160386000_2023.10.21.23297352v3.30","unstructured":"Statement by the Malaria Policy Advisory Group on the urgent need to address the high prevalence of pfhrp2\/3 gene deletions in the Horn of Africa and beyond (2021), (available at https:\/\/www.who.int\/news\/item\/28-05-2021-statement-by-the-malaria-policy-advisory-group-on-the-urgent-need-to-address-the-high-prevalence-of-pfhrp2-3-gene-deletions-in-the-horn-of-africa-and-beyond)."},{"key":"2024010921160386000_2023.10.21.23297352v3.31","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00155-0"},{"key":"2024010921160386000_2023.10.21.23297352v3.32","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1111\/eva.13077","article-title":"Incorporating genetic selection into individual-based models of malaria and other infectious diseases","volume":"13","year":"2020","journal-title":"Evol. Appl"},{"key":"2024010921160386000_2023.10.21.23297352v3.33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6344"},{"key":"2024010921160386000_2023.10.21.23297352v3.34","doi-asserted-by":"crossref","unstructured":"T. J. C. Anderson , S. Nair , M. McDew-White , I. H. Cheeseman , S. Nkhoma , F. Bilgic , R. McGready , E. Ashley , A. P. Phyo , N. J. White , F. Nostenb , Population parameters underlying an ongoing soft sweep in southeast Asian malaria parasites. Mol. Biol. Evol. 34, msw228 (2016).","DOI":"10.1093\/molbev\/msw228"},{"key":"2024010921160386000_2023.10.21.23297352v3.35","doi-asserted-by":"crossref","unstructured":"R. Verity , O. Aydemir , N. F. Brazeau , O. J. Watson , N. J. Hathaway , M. K. Mwandagalirwa , P. W. Marsh , K. Thwai , T. Fulton , M. Denton , A. P. Morgan , J. B. Parr , P. K. Tumwebaze , M. Conrad , P. J. Rosenthal , D. S. Ishengoma , J. Ngondi , J. Gutman , M. Mulenga , D. E. Norris , W. J. Moss , B. A. Mensah , J. L. Myers-Hansen , A. Ghansah , A. K. Tshefu , A. C. Ghani , S. R. Meshnick , J. A. Bailey , J. J. Juliano , The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11, 2107 (2020).","DOI":"10.1038\/s41467-020-15779-8"},{"key":"2024010921160386000_2023.10.21.23297352v3.36","unstructured":"T. L. Symons , \u201cCHAI Commodities Methodology\u201d (2022), (available at https:\/\/clintonhealth.app.box.com\/s\/3l7zni6ylp00a1oc6194re1s8nfdnzp0)."},{"key":"2024010921160386000_2023.10.21.23297352v3.37","doi-asserted-by":"publisher","DOI":"10.2307\/2407703"},{"key":"2024010921160386000_2023.10.21.23297352v3.38","doi-asserted-by":"crossref","first-page":"ofad149","DOI":"10.1093\/ofid\/ofad149","article-title":"Examining the Early Distribution of the Artemisinin-Resistant Plasmodium falciparum kelch13 R561H Mutation in Areas of Higher Transmission in Rwanda","volume":"10","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024010921160386000_2023.10.21.23297352v3.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101746"},{"key":"2024010921160386000_2023.10.21.23297352v3.40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-021-01365-y","article-title":"Author Correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"27","year":"2021","journal-title":"Nat. Med"},{"key":"2024010921160386000_2023.10.21.23297352v3.41","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2022.1041896"},{"key":"2024010921160386000_2023.10.21.23297352v3.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002181"},{"key":"2024010921160386000_2023.10.21.23297352v3.43","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2214-109X(15)00162-X","article-title":"Optimum population-level use of artemisinin combination therapies: A modelling study","volume":"3","year":"2015","journal-title":"The Lancet Global Health"},{"key":"2024010921160386000_2023.10.21.23297352v3.44","unstructured":"O. J. Watson , OJWatson\/hrpup: v0.2.0 (2023; https:\/\/zenodo.org\/record\/8082488)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.10.21.23297352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:43:37Z","timestamp":1768506217000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.10.21.23297352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,22]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1101\/2023.10.21.23297352","relation":{},"subject":[],"published":{"date-parts":[[2023,10,22]]},"subtype":"preprint"}}